Brief: FORWARD PHARMA AGREES TO ENTER INTO SETTLEMENT AND LICENSE AGREEMENT WITH BIOGEN

Forward Pharma A/S

17/01/2017 16:01

Jan 17 (Reuters) - Forward Pharma A/S  FWP.O  
    * FORWARD PHARMA AGREES TO ENTER INTO SETTLEMENT AND LICENSE 
AGREEMENT WITH BIOGEN 
    * BOARD IS CONSIDERING BOTH STOCK BUYBACKS AS WELL AS CASH 
DISTRIBUTIONS 
    * UNDER CERTAIN CIRCUMSTANCES, BIOGEN TO ALSO BE OBLIGATED 
TO PAY FORWARD ROYALTIES OF UP TO 10-20% OF NET SALES OF BIOGEN 
PRODUCTS 
    * EVALUATING WAY TO DELIVER DIRECTLY TO ITS SHAREHOLDERS A 
SUBSTANTIAL PORTION OF CASH IT WILL BE RECEIVING FROM BIOGEN 
 
Source text for Eikon:  ID:nGNXNNYNJa  
Further company coverage:  FWP.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))